Showing results (81-90 of 291) with videos related to
Sort By:
Pageof 30
Journal of Cancer Research and Clinical Oncology|November 9, 2014
Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)Leonard Christopher Schmeel, Frederic Carsten Schmeel, Christoph Coch, et al.Journal of Cancer Research and Clinical Oncology|April 22, 2010
Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)C Hontscha, Y Borck, H Zhou, et al.Hematological Oncology|January 29, 2014
Piceatannol exhibits selective toxicity to multiple myeloma cells and influences the Wnt/ beta-catenin pathwayFrederic Carsten Schmeel, Leonard Christopher Schmeel, Young Kim, et al.Cancer Medicine|December 16, 2024
Balancing CIK Cell Cancer Immunotherapy and PPAR Ligands: One Potential Therapeutic Application for CNS MalignanciesKira Vordermark, JingJing Pu, Amit Sharma, et al.Molecular Medicine (Cambridge, Mass.)|June 8, 2011
Effect of oxygen levels on the physiology of dendritic cells: implications for adoptive cell therapyDiahnn Futalan, Chien-Tze Huang, Ingo G H Schmidt-Wolf, et al.Journal of Immunology Research|April 18, 2014
Clinical studies applying cytokine-induced killer cells for the treatment of gastrointestinal tumorsClara E Jäkel, Annabelle Vogt, Maria A Gonzalez-Carmona, et al.Molecular Medicine (Cambridge, Mass.)|March 24, 2007
Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activationDavorka Messmer, Ikusuke Hatsukari, Naoko Hitosugi, et al.International Journal of Molecular Sciences|September 9, 2014
Adoptive immunotherapy strategies with cytokine-induced killer (CIK) cells in the treatment of hematological malignanciesFrederic Carsten Schmeel, Leonard Christopher Schmeel, Sanna-Marie Gast, et al.In Vivo (Athens, Greece)|April 24, 2012
Efficacy of a proapoptotic peptide towards cancer cellsClara E Jäkel, Karoline Meschenmoser, Young Kim, et al.In Vivo (Athens, Greece)|July 10, 2008
Prevention of lethal tumor growth and generation of long-lasting immunity in vivo using CD137L and interleukin-12 gene transferYoung Kim, John W Strehl, Marcus Gorschlüter, et al.Pageof 30